Research Article

You have full text access to this OnlineOpen article

Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin

  1. Natalia Louneva,
  2. Gonzalo Huaman,
  3. Joanna Fertala,
  4. Sergio A. Jiménez*

Article first published online: 30 MAR 2006

DOI: 10.1002/art.21723

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 4, pages 1298–1308, April 2006

Additional Information

How to Cite

Louneva, N., Huaman, G., Fertala, J. and Jiménez, S. A. (2006), Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis & Rheumatism, 54: 1298–1308. doi: 10.1002/art.21723

Author Information

  1. Thomas Jefferson University, Philadelphia, Pennsylvania

*Thomas Jefferson University, Division of Rheumatology, 233 S. 10th Street, Room 509 BLSB, Philadelphia, PA 19107-5541

Publication History

  1. Issue published online: 30 MAR 2006
  2. Article first published online: 30 MAR 2006
  3. Manuscript Accepted: 19 DEC 2005
  4. Manuscript Received: 26 AUG 2005

Funded by

  • NIH. Grant Number: AM-19616

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (785K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Diletta Dolfini, Raffaella Gatta, Roberto Mantovani, NF-Y and the transcriptional activation of CCAAT promoters, Critical Reviews in Biochemistry and Molecular Biology, 2012, 47, 1, 29

    CrossRef

  2. 2
    Ariane L. Herrick, Contemporary management of Raynaudʼs phenomenon and digital ischaemic complications, Current Opinion in Rheumatology, 2011, 23, 6, 555

    CrossRef

  3. 3
    Yoav Arnson, Howard Amital, Nancy Agmon-Levin, Danny Alon, María Sánchez-Castañón, Marcos López-Hoyos, Marco Matucci-Cerinic, Gabriella Szücs, Yinon Shapira, Zoltan Szekanecz, Yehuda Shoenfeld, Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature, Autoimmunity Reviews, 2011, 10, 8, 490

    CrossRef

  4. 4
    Christos G. Mihos, Rosa T. Artola, Orlando Santana, The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review, Rheumatology International, 2011, 32, 2, 287

    CrossRef

  5. 5
    H. Y. Sadik, T. L. Moore, A. Vail, A. Murray, M. Anderson, A. Blann, A. L. Herrick, Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis, Rheumatology, 2010, 49, 5, 990

    CrossRef

  6. 6
    Farideh Jowkar, Mohammad Reza Namazi, Statins in dermatology, International Journal of Dermatology, 2010, 49, 11
    Direct Link:
  7. 7
    J. P. Burke, R. W. G. Watson, M. Murphy, N. G. Docherty, J. C. Coffey, P. R. O'Connell, Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor β1-mediated activation of intestinal fibroblasts, British Journal of Surgery, 2009, 96, 5
    Direct Link:
  8. 8
    B. J. Rabquer, Y. Hou, F. Del Galdo, G. Kenneth Haines, M. L. Gerber, S. A. Jimenez, J. R. Seibold, A. E. Koch, The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1, Rheumatology, 2009, 48, 7, 734

    CrossRef

  9. 9
    I. Badea, M. Taylor, A. Rosenberg, M. Foldvari, Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis, Rheumatology, 2008, 48, 3, 213

    CrossRef

  10. 10
    JWG Jacobs, R Geenen, Het verrassend brede werkingsspectrum van statines, Huisarts en Wetenschap, 2007, 50, 1, 47

    CrossRef

  11. 11
    Masataka Kuwana, Potential benefit of statins for vascular disease in systemic sclerosis, Current Opinion in Rheumatology, 2006, 18, 6, 594

    CrossRef

View Full Article (HTML) Get PDF (785K)